Message-based Outreach Intervention for Survivors for Ovarian Cancer

Emory University, Atlanta, GA
Ovarian CancerMessage-based Outreach Intervention for Survivors - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial tests an intervention to get ovarian cancer survivors and their at-risk relatives to consider cancer genetic services. It includes foot-in-the-door techniques, tailored/targeted print, website support, and short messages.

Eligible Conditions
  • Ovarian Cancer

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Universal genetic testing
1
SmartManage for HIV+ cancer survivors
1
YouTube Video Arm

Study Objectives

4 Primary · 7 Secondary · Reporting Duration: Up to 31 months

Up to 31 months
Number of Pages Viewed by Relatives
Number of Pages Viewed by Survivors
Number of Return Visits to Website by Relatives
Number of Return Visits to Website by Survivors
Proportion Selecting Contact Options
Proportion of Relatives Completing Telegenetic Counseling
Proportion of Relatives of Survivors Accessing the Website
Proportion of Survivors Accessing the Website
Proportion of Survivors Completing Telegenetic Counseling
Time Visiting Website by Relatives
Time Visiting Website by Survivors

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
Universal genetic testing
1
SmartManage for HIV+ cancer survivors
1
YouTube Video Arm

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

4 Treatment Groups

Standard Outreach for Close Relatives
1 of 4
Standard Outreach for Survivors
1 of 4
Message-based Outreach Intervention for Close Relatives
1 of 4
Message-based Outreach Intervention (MBI) for Survivors
1 of 4

Active Control

Experimental Treatment

1240 Total Participants · 4 Treatment Groups

Primary Treatment: Message-based Outreach Intervention for Survivors · No Placebo Group · N/A

Message-based Outreach Intervention for Close Relatives
Behavioral
Experimental Group · 1 Intervention: Message-based Outreach Intervention for Close Relatives · Intervention Types: Behavioral
Message-based Outreach Intervention (MBI) for Survivors
Behavioral
Experimental Group · 1 Intervention: Message-based Outreach Intervention for Survivors · Intervention Types: Behavioral
Standard Outreach for Close Relatives
Behavioral
ActiveComparator Group · 1 Intervention: Standard Outreach for Close Relatives · Intervention Types: Behavioral
Standard Outreach for Survivors
Behavioral
ActiveComparator Group · 1 Intervention: Standard Outreach for Survivors · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 31 months

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,275 Previous Clinical Trials
41,233,572 Total Patients Enrolled
285 Trials studying Ovarian Cancer
72,626 Patients Enrolled for Ovarian Cancer
Emory UniversityLead Sponsor
1,558 Previous Clinical Trials
2,764,501 Total Patients Enrolled
2 Trials studying Ovarian Cancer
90 Patients Enrolled for Ovarian Cancer
Colleen McBride, PhDPrincipal InvestigatorEmory University

Eligibility Criteria

Age 18+ · All Participants · 9 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been diagnosed with cancer in your ovaries, fallopian tubes or peritoneum.
You were living in Georgia when you were diagnosed.
You are still alive according to the registry's records.
Your mailing address is in the GSR records.
You must be at least 25 years old.
You can use the internet.
One of your close family members who can understand English can participate.
You are not in jail or a mental institution.
Your information is in the Georgia Cancer Registry (GSR).
References

Frequently Asked Questions

Are there any patient recruitment opportunities with this research endeavor?

"Indubitably, clinicaltrials.gov attests that this experiment is presently searching for participants. This project was initially posted on 24th July 2021 and had its latest update on 18th October 2022. 1 trial site must find 1240 patients to fill the study's quota." - Anonymous Online Contributor

Unverified Answer

What is the cap on participants in this research?

"Affirmative. Clinicaltrials.gov declares that this medical experiment, which was published on July 24th 2021, is actively enrolling patients. A total of 1240 individuals are necessary for recruitment from 1 location." - Anonymous Online Contributor

Unverified Answer

What results can be expected from this medical experiment?

"This medical trial will last a maximum of 31 months and seeks to measure the proportion of survivors completing telegenic counselling as its primary outcome. As secondary metrics, researchers are looking at number of return visits to the website by both survivors and relatives; in addition, they plan on measuring duration (in minutes) that survivors spend on said website." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top